These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7418184)

  • 21. Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action.
    Sung RJ; Waxman HL; Elser B; Juma Z
    Clin Invest Med; 1980; 3(1-2):41-7. PubMed ID: 7009003
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of isoptin in auricular fibrillation in a patient with Wolff-Parkinson-White syndrome].
    Golitsyn SP; Sokolov SF; Mazur NA
    Kardiologiia; 1979 Jul; 19(7):102-5. PubMed ID: 470312
    [No Abstract]   [Full Text] [Related]  

  • 23. Verapamil in life-threatening tachyarrhythmias.
    Gotsman MS; Lewis BS; Bakst A; Mitha AS
    S Afr Med J; 1972 Dec; 46(51):2017-9. PubMed ID: 4651883
    [No Abstract]   [Full Text] [Related]  

  • 24. [Discrepant effects of oral and intravenous verapamil on A-V conduction in patients with ventricular preexcitation and atrial fibrillation].
    Petri H; Kafka W; Rudolph W
    Herz; 1983 Jun; 8(3):144-52. PubMed ID: 6347850
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-arrhythmic therapy with verapamil by intravenous infusion].
    Furlanello F; Piccolo E; Disertori M; Trevi GP; Lanzetta T; Miori
    Minerva Med; 1975 May; 66(39):1887-903. PubMed ID: 1128829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic effects of verapamil.
    Singh BN; Nademanee K; Feld G
    Angiology; 1983 Sep; 34(9):572-90. PubMed ID: 6351674
    [No Abstract]   [Full Text] [Related]  

  • 27. Tachyarrhythmias in Wolff-Parkinson-White syndrome. Treatment and prevention.
    Tonkin AM; Gallagher JJ; Wallace AG
    JAMA; 1976 Mar; 235(9):947-9. PubMed ID: 946127
    [No Abstract]   [Full Text] [Related]  

  • 28. Misuse of verapamil in pre-excited atrial fibrillation.
    Garratt C; Antoniou A; Ward D; Camm AJ
    Lancet; 1989 Feb; 1(8634):367-9. PubMed ID: 2563516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical results with verapamil in intravenous administration in the emergency therapy of cardiac arrhythmias].
    Amoroso A
    Minerva Med; 1975 May; 66(39):1904-13. PubMed ID: 1128830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
    Honerjäger P; Schmidt G
    Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.
    Rosen MR; Wit AL; Hoffman BF
    Am Heart J; 1975 May; 89(5):665-73. PubMed ID: 1091129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias.
    Sellers TD; Kirchhoffer JB; Modesto TA
    Prog Clin Biol Res; 1987; 230():283-99. PubMed ID: 3295883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digitalis and verapamil in atrial fibrillation and flutter. Is verapamil now the preferred agent?
    Klein HO; Kaplinsky E
    Drugs; 1986 Mar; 31(3):185-97. PubMed ID: 3519173
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
    Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction.
    Klein HO; Kaplinsky E
    Am J Cardiol; 1982 Oct; 50(4):894-902. PubMed ID: 6751065
    [No Abstract]   [Full Text] [Related]  

  • 36. Wolff-Parkinson-White syndrome in children: electrophysiologic and pharmacologic characteristics.
    Gillette PC; Garson A; Kugler JD
    Circulation; 1979 Dec; 60(7):1487-95. PubMed ID: 498476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supraventricular tachycardia: mechanisms and management.
    Josephson ME; Kastor JA
    Ann Intern Med; 1977 Sep; 87(3):346-58. PubMed ID: 332025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
    Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS
    Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of verapamil on supraventricular tachycardia in children.
    Porter CJ; Gillette PC; Garson A; Hesslein PS; Karpawich PP; McNamara DG
    Am J Cardiol; 1981 Sep; 48(3):487-91. PubMed ID: 7270455
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of intravenous verapamil in cardiac arrhythmias.
    Slome R
    S Afr Med J; 1973 Jun; 47(21):913-4. PubMed ID: 4711004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.